-
Chris Labaki
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
-
Eddy Saad
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Katrine N Madsen
Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.
-
Charbel Hobeika
Department of Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH.
-
Kevin Bi
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Broad Institute, Cambridge, MA, USA.
-
Michel Alchoueiry
Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
-
Sabrina Camp
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Yue Hou
College of Metropolitan Transportation, Beijing University of Technology, Beijing 100124, China.
-
Ziad Bakouny
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Sayed Matar
Department of Pathology, Brigham and Women's Hospital, Boston, MA.
-
Nourhan El Ahmar
Department of Pathology, Brigham and Women's Hospital, Boston, MA.
-
Jackson Nyman
Dana-Farber Cancer Institute, Boston, Massachusetts.
-
Long Zhang
Hefei Institute of Physical Science, Chinese Academy of Sciences Hefei 230036 PR China liuyong@aiofm.ac.cn zhanglong@aiofm.ac.cn wangchongwen1987@126.com.
-
Carmen Priolo
Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
-
Rishabh Rout
Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.
-
Melissa Daou
Department of Medicine, Yale University, New Haven, CT.
-
Damir Khabibullin
Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
-
Samer Salem
Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
-
Nicholas Schindler
Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.
-
Renée Maria Saliby
Center of Molecular and Cellular Oncology (CMCO), Yale School of Medicine, New Haven, CT.
-
Kevin Meli
Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
-
J Connor Wells
BC Cancer Agency, Vancouver, Canada.
-
Erica Pimenta
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Kosuke Takemura
Shiga University Faculty of Economics, 1-1-1 Banba, Hikone, Shiga, 522-8522, Japan.
-
Jihye Park
Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, 11794, USA.
-
Marc Eid
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Karl Semaan
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Jingxin Fu
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Thomas Denize
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
-
Razane El Hajj Chehade
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Marc Machaalani
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Rashad Nawfal
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Wassim Daoud Khatoun
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Mustafa Saleh
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Jad El Masri
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Nina Rossa Haddad
Johns Hopkins University School of Medicine, Baltimore, MD.
-
Wenxin Xu
From Dana-Farber Cancer Institute, Boston, MA, USA.
-
Bradley A McGregor
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
-
Michelle S Hirsch
Department of Pathology, Brigham and Women's Hospital, Boston, MA.
-
Wanling Xie
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
-
Daniel Y C Heng
Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
-
David F McDermott
Department of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
-
Sabina Signoretti
Broad Institute, Cambridge, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.
-
Eliezer M Van Allen
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Harvard University, Boston, Massachusetts.
-
Sachet A Shukla
Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Texas, Houston, TX.
-
Toni K Choueiri
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
-
Elizabeth P Henske
Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
-
David A Braun
Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
